What Causes Erythroblastosis

Erythroblastosis fetalis is hemolytic anemia in the fetus (or neonate, as erythroblastosis neonatorum) caused by transplacental transmission of maternal antibodies to fetal red blood cells. The disorder usually results from incompatibility between maternal and fetal blood groups, often Rho(D) antigens.

What is erythroblastosis fetalis and how it can be prevented?

Erythroblastosis fetalis is a preventable condition. A medication called Rh immunoglobulin (Rhig), also known as RhoGAM, can help prevent Rh sensitization. This medication prevents the pregnant woman from developing Rh-positive antibodies.

What happens during Erythroblastosis?

It occurs when your baby’s red blood cells break down at a fast rate. It’s also called erythroblastosis fetalis. Hemolytic means breaking down of red blood cells. Erythroblastosis means making immature red blood cells.